Cutaneous manifestations in leukemia patients

Semin Oncol. 2016 Jun;43(3):359-65. doi: 10.1053/j.seminoncol.2016.02.020. Epub 2016 Feb 23.

Abstract

Cutaneous complications are common in patients with leukemia. However, the cause is not always immediately clear, as there are often numerous potential etiologies. Thrombocytopenia or coagulopathy can result in ecchymoses or petechiae, whereas extramedullary (EM) involvement by leukemia can present as a rash. Leukemia can also result in skin manifestations via indirect means, including several types of paraneoplastic phenomena. Moreover, various agents routinely used to treat leukemia-most notably cytarabine (cytosine arabinoside)-can precipitate quite profound skin eruptions. Finally, infections, including fungal invasion of the skin, can be responsible for rashes, as can the vast array of antimicrobials that are administered to leukemia patients.

Keywords: Extramedullary leukemia; Granulocytic sarcoma; Leukemia; Leukemia cutis; Paraneploastic phenomena.

Publication types

  • Review

MeSH terms

  • Adenine Nucleotides / adverse effects
  • Adenine Nucleotides / therapeutic use
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Arabinonucleosides / adverse effects
  • Arabinonucleosides / therapeutic use
  • Clofarabine
  • Cytarabine / adverse effects
  • Cytarabine / therapeutic use
  • Dermatomycoses / etiology
  • Dermatomycoses / pathology
  • Etoposide / adverse effects
  • Etoposide / therapeutic use
  • Humans
  • Leukemia / complications
  • Leukemia / drug therapy
  • Leukemia / pathology*
  • Mastocytosis / pathology
  • Mastocytosis / secondary
  • Niacinamide / adverse effects
  • Niacinamide / analogs & derivatives
  • Niacinamide / therapeutic use
  • Paraneoplastic Syndromes / etiology
  • Paraneoplastic Syndromes / pathology*
  • Phenylurea Compounds / adverse effects
  • Phenylurea Compounds / therapeutic use
  • Skin Diseases, Bacterial / etiology
  • Skin Diseases, Bacterial / pathology
  • Skin Neoplasms / pathology*
  • Skin Neoplasms / secondary
  • Sorafenib

Substances

  • Adenine Nucleotides
  • Antineoplastic Agents
  • Arabinonucleosides
  • Phenylurea Compounds
  • Cytarabine
  • Niacinamide
  • Etoposide
  • Clofarabine
  • Sorafenib